Peroxisome proliferators and cytochrome P4504A induction

Annals of the New York Academy of Sciences

Volumn 804, Issue , 1996, Pages 328-340

  Gibson, G Gordon ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIFONAZOLE; CALCIUM ION; CIPROFIBRATE; CLOFIBRATE; CLOTRIMAZOLE; CYTOCHROME P450; METHYLCLOFENAPATE; NAFENOPIN; OXYGENASE; PEROXISOME PROLIFERATOR; PIRINIXIC ACID; PROTEIN KINASE C; TOMELUKAST; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WY 16643;

AMINO ACID SEQUENCE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CONFERENCE PAPER; DRUG ABSORPTION; DRUG BIOAVAILABILITY; ENZYME ACTIVATION; ENZYME INDUCTION; EVOLUTION; GENETIC TRANSFECTION; HUMAN; MITOGENESIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PEROXISOME; PLEIOTROPY;

EID: 0030477538     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb18626.x     Document Type: Conference Paper

References (51)

1. GIBSON, G.G. & B.G. LAKE. Eds. 1993. Peroxisomes: Biology and Importance in Toxicology and Medicine. Taylor and Francis. London.
2. MOODY, D.E. 1994. Peroxisome proliferation: An overview. In Peroxisome Proliferators: Unique Inducers of Drug-metabolizing Enzymes. D.E. Moody, Ed.: 1-26. CRC Press. Boca Raton, Florida.
3. NELSON, D.R., T. KAMATAKI, D.J. WAXMAN, F.P. GUENGERICH, R.W. ESTABROOK, R. FEYEREISEN, F.J. GONZALEZ, M.J. COON, I.C. GUNSALUS, O. GOTOH, K. OKUDA & D.W. NEBERT. 1993. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature. DNA Cell Biol. 12: 1-51.
4. GIBSON, G.G. & P. SKETT. 1994. Introduction to Drug Metabolism. 2nd ed. Blackie. Glasgow.
5. WATERMAN, M.R. & E.F. JOHNSON, Eds. 1991. Methods in Enzymology. Cytochrome P450, vol. 206. Academic Press. San Diego, California.
6. GIBSON, G.G. & B.G. LAKE. 1991. Induction protocols for the cytochrome P4504A subfamily in animals and primary hepatocyte culture. Meth.Enzymol. 206: 353-364.
7. ISSEMANN, I. & S. GREEN. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347: 645-650.
8. ALDRIDGE, T.C., J.D. TUGWOOD, & S. GREEN. 1995. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem.J. 306: 473-479.
9. PALMER, C.N.A., M-H. HSU, A.S. MUERHOFF, K.J. GRIFFIN & E. JOHNSON. 1994. Interaction of the peroxisome proliferator-activated receptor alpha with the retinoid X receptor alpha unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1 binding site in the CYP4A6 promoter. J.Biol.Chem. 269: 18083-18089.
10. MOODY, D.E., J.K. REDDY, B.G. LAKE, J.A. POPP & D.H. RIESE. 1991. Peroxisome proliferation and non-genotoxic carcinogenesis. Fund.App. Toxicol. 16: 233-248.
11. LAKE, B.G. 1995. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Ann.Rev.Pharmacol.Toxicol. 35: 483-507.
12. SHARMA R.J., B.G. LAKE, J.R. FOSTER & G.G. GIBSON. 1988. Co-induction of microsomal cytochrome P452 and the peroxisomal fatty acid beta-oxidation pathway in the rat by clofibratc and di-(2-ethylhexyl) phthalate: Dose response studies. Biochem.Pharmacol. 37: 1203-1206.
13. MITCHELL, A.M., J.-C. LHUGENOT, J.W. BRIDGES & C.R. ELCOMBE, C.R. 1985. Identification of the proximate peroxisome proliferator(s) derived from di-(2-ethylhexyl) phthalate. Toxicol. App. Pharmacol. 80: 23-32.
14. WU, H.Q., J. MASSET-BROWN, D.J. TWEEDIE, L. MILEWICH, R.A. FRENKEL, C. MARTIN-WIXTROM, R.W. ESTABROOK & R.A. PROUGH 1989. Induction of microsomal NADPH-cytochrome P450 reductase and cytochrome P4504A1 by dehydroepiandrosterone in rats: A possible peroxisome proliferator. Cancer Res. 49: 2337-2343.
15. HUANG, S. & G.G. GIBSON. 1992. Species and congener specific induction of hepatic CYP4A by polychlorinated biphenyls. Biochem.Pharmacol. 43: 637-642.
16. EACHO, P., P.S. FOXWORTHY, W.D. JOHNSON, D.M. HOOVER & S.L. WHITE. 1986. Hepatic peroxisomal changes induced by tetrazole-substituted alkoxyacetophenones in rats and comparison with other species. Toxicol. App. Pharmacol. 83: 430-438.
17. SABZEVARI, O., M. HATCHER, M. O'SULLIVAN, P. KENTISH & G.G. GIBSON. 1995. Comparative induction of cytochrome P4504A in rat hepatocyte culture by the peroxisome proliferators, bifonazole and clofibrate. Xeno. 25: 395-403.
18. DIAZ, M., E. CHINJE, P. KENTISH, B. JARNOT, M. GEORGE & G.G. GIBSON. 1993. Chlorotrifluoroethylene trimer and tetramer are inducers of the CYP4A subfamily. Biochem. Pharmacol. 46: 1076-1080.
19. DEL RASO, N.J., C.S. GODIN, C.E. JONES, H.G. WALL, D.R. MATTIE & E.D. FLEMING. 1991. Comparative hepatotoxicity of two polychlorofluoroethylenes (3.1 oils) and two chlorofluoroethylene oligomers in male Fischer 344 rats. Fund. App. Toxicol. 17: 550-562.
20. VINEGAR, A., C.S. Seckel, D.L. POLLARD, E.R. KINNKEAD, R.B. CONOLLY & M.E. ANDERSON. 1992. Polychlorotrifluoroethylene oligomer pharmacokinetics in Fischer 344 rats: Development of a physiologically based model. Fund. App. Toxicol. 18: 504-514.
21. 8 chlorotrifluoroethylene oligomers to their corresponding acids. Toxicol. Lett. 59: 41-49.
22. BRASHEAR, W.T., R.J. GREEN & D.A. MAHLE. 1992. Structural determination of the carboxylic acid metabolites of polychlorotrifluoroethylene. Xeno. 22: 499-506.
23. HORIE, S., N. FUKUMORI &T. SUGA. 1991. Induction of hepatic peroxisomes by a new non-carboxylate containing drug, bifonazole. Toxicol. Lett. 55: 249-254.
24. NAKAOKA, M. & H. HAKUSHI. 1987. Identification of a new hypoglycaemic agent, midaglazole. Xeno. 17: 1329-1339.
25. LEWIS, D.F.V. & B.G. LAKE. 1993. Interaction of some peroxisome proliferators with the mouse liver peroxisome proliferator-activated receptor (PPAR): A molecular modelling and quantitative structure-activity relationship (QSAR). Xeno. 23: 79-96.
26. SILVER, R.B. 1990. Calcium and cellular clocks orchestrate cell division. Ann. N.Y. Acad. Sci. 582: 207-212.
27. HESKETH, T.R., J.P. MOORE, J.D. MORRIS, M.V. TAYLOR, J. ROGERS, G.A. SMITH & J.C. METCALFE. 1985. A common sequence of calcium and pH signals in the mitogenic stimulation of eukaryotic cells. Nature. 313: 481-484.
28. WATANABE, T. & T. SUGA. 1988. Suppression of clofibrate-induced peroxisome proliferation by nicardipine, a calcium antagonist. FEBS Lett. 232: 293-297.
29. ITOGA, H., H. TAMURA, T. WATANABE & T. SUGA. 1990. Characteristics of the suppressive effect of nicardipine on peroxisome induction in rat liver. Biochim. Biophys. Acta. 1051: 21-28.
30. WATANABE, T., H. IOGA, S. OKAWA, H. TAMURA & T. SUGA. 1991. Co-suppression by nicardipine, a calcium antagonist, of induction of microsomal lauric acid hydroxylation with peroxisome proliferation in clofibrate treated rat liver. Chem. Pharm. Bull. 39: 1320-1322.
31. WATANABE, T., T. OOKAWA, H. ITOGA, T. IMANAKA & T. SUGA. 1992. Involvement of calcodulin- and protein kinase C-related mechanism in an induction process of peroxisomal fatty acid oxidation-related enzymes by hypolipidaemic peroxisome proliferators. Biochim. Biophys. Acta 1135: 84-90.
32. OCHSNER, M., J. CREBA, J. WALKER, P. BENTLET & S.M. MUAKKASSAH-KELLY. 1990. Nafenopin, a hypolipidaemic and non-genotoxic hepatocarcinogen increases intracellular calcium and transiently decreases intracellular pH in hepatocytes without generation of inositol phosphates. Biochem. Pharmacol. 40: 2247-2257.
33. BENNETT, A.M. & G.M. WILLIAMS. 1993. Alteration of rat liver endoplasmic reticulum calcium-ATPase thiol integrity by ciprofibrate, a peroxisome proliferator. Biochem. Pharmacol. 45: 2093-2098.
34. SHACKLETON, G.L., G.G. GIBSON, R.J. SHARMA, D. HOWES, S. ORRENIUS & G.E.N. KASS. 1995. Diverse mechanisms of calcium mobilization by peroxisome proliferators in rat hepatocytes. Toxicol. App. Pharmacol. 130: 294-303.
35. KESSLER, D.S. & D.E. LEVY. 1991. Protein kinase activity is required for an early step in interferon-alpha signalling. J. Biol. Chem. 266: 23471-23476.
36. BOYLE, W.J., T. SMEAL, T., L.H.K. DEFIZE, P. ANGEL, J.R. WOODGETT, M. KARIN & T. HUNTER. 1991. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activities. Cell 64: 573-584.
37. SMEAL, T., B. BINETRUY, D. MERCOLA, M. BIRRER & M. KARIN. 1991. Oncogenic and transcriptional cooperation with Ha-ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354: 494-496.
38. POWER, R.F., O.M. CONNEELY & B.W. O'MALLEY. 1992. New insights into activation of the steroid hormone receptor superfamily. Tr. Pharmacol. Sci. 13: 318-323.
39. GOTTLICHER, M., E. WIDMARK, Q LI & J.-A. GUSTAFSSON. 1992. Fatty acids activate a chimaera of the clofibric acid-activated receptor and the glucocorticoid receptor. Prox. Natl. Acad. Sci. USA 89: 4653-4657.
40. KELLER, H., C. DREYER, J. MEDIN, A. MAHFOUDI, K. OZATO & W. WAHLI. 1993. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator activated receptor - retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA 90: 2160-2164.
41. ORELLANA, A., P.C. HIDALGO, M.N. MORALES, D. MEZZANO & M. BRONFMAN. 1990. Palmitoyl CoA and the acyl CoA thioester of the carcinogenic peroxisome proliferator ciprofibrate, potentiate diacylglycerol-activated protein kinase C by decreasing the phosphatidylserine requirement of the enzyme. Eur. J. Biochem. 190: 57-61.
42. BOJES, H.K., B.J. KELLER & R.G. THURMAN. 1992. Wy-14,643 stimulates hepatic protein kinase C activity. Toxicol. Lett. 62: 317-322.
43. BOJES, K.K. & R.G. THURMAN. 1994. Peroxisome proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo. Toxicol. App. Pharmacol. 126: 233-239.
44. ORELLANO, A., L. HOLUIGUE, P.C. HIDALGO, V. FAUNDEZ, A. GONZALEZ & M. BRONFMAN, 1993. Ciprotibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of the epidermal growth factor receptor in isolated hepatocytes. Eur. J. Biochem. 215: 903-906.
45. CAYEN, M.N., E.S. FERDINANDI, E. GRESELIN, W.T. ROBINSON & D. DVORNIK. 1977. Clofibrate and clofibric acid: Comparison of the metabolic disposition in rats and dogs. J. Pharmacol. Ex. Ther. 200: 33-43.
46. LAKER, M.E. & P.A. MAYES. 1979. The immediate and long-term effects of clofibrate on the metabolism of the perfused rat liver. Biochem. Pharmacol. 28: 2813-282827.
47. BALDWIN, J.R., D.T. WITIAK & D.R. FELLER. 1980. Disposition of clofibrate in the rat: Acute and chronic administration. Biochem. Pharmacol. 29: 3143-3154.
48. EASON, C.T., P. POWLES, G. HENRY, A.J. SPENCER, A. PATTISON & F.W. BONNER. 1989. The comparative pharmacokinetics and gastric toxicity of bezafibrate and ciprofibrate in the rat. Xeno. 19: 913-925.
49. GIBSON, G.G., M.J. DIAZ, E. CHINJE & P. KENTISH. 1994. Induction of cytochromes P450 by peroxisome proliferators. In Peroxisome Proliferators: Unique Inducers of Drug-metabolizing Enzymes. D.E. MOODY, Ed.: 27-36. CRC Press. Boca Raton, Florida.
50. CHINJE, E. 1992. Ph.D. Thesis. University of Surrey, England: Regulation and Expression of Cytochrome P4504A1 and its Relationship to Peroxisome Proliferation.
51. ELCOMBE, C.R. & A.M. MITCHELL, A.M. 1986. Peroxisome proliferation due to di-(2-ethylhexyl)phthalate: Species differences and possible mechanisms. Environ. Health Perspec. 70: 211-216.